An Open Labeled, Single-center, Phase I Study Assessing the Safety and Efficacy of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 10 Apr 2017
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Peripheral ischaemia
- Focus Therapeutic Use
- Sponsors Pharmicell
- 03 Apr 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2020.
- 03 Apr 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2020.
- 03 Apr 2017 Planned initiation date changed from 1 Jul 2015 to 1 Jul 2017.